158
Views
2
CrossRef citations to date
0
Altmetric
Rheumatoid Arthritis

Tocilizumab can efficiently prevent bone destruction in patients with recent-onset rheumatoid arthritis

Pages 966-971 | Received 08 Jul 2020, Accepted 26 Nov 2020, Published online: 18 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ryu Watanabe, Kosaku Murakami, Toshimitsu Fujisaki, Hiromu Ito, Koichi Murata, Wataru Yamamoto, Takayuki Fujii, Hideo Onizawa, Akira Onishi, Masao Tanaka, Akio Morinobu & Motomu Hashimoto. (2023) Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort. Immunological Medicine 46:2, pages 84-92.
Read now

Articles from other publishers (1)

Annett Klinder, Janine Waletzko-Hellwig, Marie-Luise Sellin, Anika Seyfarth-Sehlke, Markus Wolfien, Franziska Prehn, Rainer Bader & Anika Jonitz-Heincke. (2022) Effects of the Interleukin-6 Receptor Blocker Sarilumab on Metabolic Activity and Differentiation Capacity of Primary Human Osteoblasts. Pharmaceutics 14:7, pages 1390.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.